Abeona Therapeutics Inc.: Abeona Therapeutics Announces Appointment of Mohamad Tabrizi as Chief Business Officer

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Mohamad Tabrizi, M.S., M.B.A., as Senior Vice President, Chief Business Officer ...
The Manila Times

Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Mohamad Tabrizi, M.S., M.B.A., as Senior Vice ...

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Detailed price information for Abeona Therapeutics (ABEO-Q) from The Globe and Mail including charting and trades.

Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy

Detailed price information for Abeona Therapeutics (ABEO-Q) from The Globe and Mail including charting and trades.

I Survived a Dangerous and Painful Skin Disorder

ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw ...
The Manila Times

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in ...
Managed Healthcare Executive

2025 FDA dermatology approvals: A new gene therapy and two targeted therapies

Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...